Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis

被引:0
|
作者
Anwar, Insa Binte [1 ]
Ahmed, Iqra Furqan [1 ]
Mahmood, Fariha [1 ]
Haseeb, Abdul [2 ]
Ahmed, Khabab Abbasher Hussien Mohamed [3 ]
机构
[1] Liaquat Natl Med Coll, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Univ Khartoum, Fac Med, Khartoum 11111, Sudan
来源
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词
D O I
10.1097/MS9.0000000000002839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:20 / 23
页数:4
相关论文
共 50 条
  • [41] Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression
    David Adams
    Vincent Algalarrondo
    Michael Polydefkis
    Nitasha Sarswat
    Michel S. Slama
    Jose Nativi-Nicolau
    Orphanet Journal of Rare Diseases, 16
  • [42] Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
    Schmidt, Hartmut H.
    Wixner, Jonas
    Plante-Bordeneuve, Violaine
    Munoz-Beamud, Francisco
    Llado, Laura
    Gillmore, Julian D.
    Mazzeo, Anna
    Li, Xingyu
    Arum, Seth
    Jay, Patrick Y.
    Adams, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (06) : 1646 - 1657
  • [43] Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
    Grogan, Martha
    Hawkins, Philip N.
    Kristen, Arnt V.
    Berk, John L.
    Suhr, Ole B.
    Lin, Hollis
    Merkel, Madeline
    McManus, Anastasia
    Powell, Christine
    Vest, John
    Karsten, Verena
    Judge, Daniel P.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S9 - S10
  • [44] Liver-directed drugs for transthyretin-mediated amyloidosis
    Brannagan, Thomas H.
    Berk, John L.
    Gillmore, Julian D.
    Maurer, Mathew S.
    Waddington-Cruz, Marcia
    Fontana, Marianna
    Masri, Ahmad
    Obici, Laura
    Brambatti, Michela
    Baker, Brenda F.
    Hannan, Lisa A.
    Buchele, Gustavo
    Viney, Nick J.
    Coelho, Teresa
    Nativi-Nicolau, Jose
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 (04) : 228 - 237
  • [45] An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Plante-Bordeneuve, Violaine
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 473 - 481
  • [46] Eplontersen: a promising breakthrough in treating hereditary transthyretin amyloidosis-related polyneuropathy
    Qazi, Muhammad Saeed
    Tariq, Muhammad Burhan
    Farhan, Kanza
    Salomon, Izere
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4336 - 4337
  • [47] HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Ajroud-Driss, Senda
    Berk, John L.
    Adams, David
    Gillmore, Julian
    Lin, Kon-Ping
    Kale, Parag
    Koike, Haruki
    Aldinc, Emre
    Chen, Chongshu
    Vest, John
    Obici, Laura
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S40 - S41
  • [48] Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Obici, Laura
    Ajroud-Driss, Senda
    Lin, Kon-Ping
    Berk, John L.
    Gillmore, Julian D.
    Kale, Parag
    Koike, Haruki
    Danese, David
    Aldinc, Emre
    Chen, Chongshu
    Vest, John
    Adams, David
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1759 - 1775
  • [49] Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Labeyrie, Celine
    Merkel, Madeline
    Sethi, Sakshi
    Popadic, Lyuba
    Yang, Hongbo
    Sweetser, Marianne T.
    Lin, Hollis
    Adams, David
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [50] Long-term Integrated Safety of Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Gillmore, Julian
    Berk, John
    Dispenzieri, Angela
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Sekijima, Yoshiki
    Sweetser, Marianne T.
    Arum, Seth
    Wang, Jing Jing
    White, Matthew T.
    Maurer, Mathew
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S67 - S68